Skip to content

Efficacy of the Use of Vaginal Balls for the Improvement of Urinary Incontinence and Sexual Function in Women.

Efficacy of the Use of Vaginal Balls for the Improvement of Urinary Incontinence and Sexual Function in Women. Randomized Control Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05732844
Enrollment
64
Registered
2023-02-17
Start date
2022-10-05
Completion date
2023-01-27
Last updated
2023-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual Dysfunction, Stress Urinary Incontinence, Urinary Incontinence

Keywords

vaginal spheres, physiotherapy, pelvic floor muscle trainning

Brief summary

Asess if adding vaginal spheres treatment to the conventional Pelvic Floor Muscle Trainning (PFMT) produces a greater decrease in the severity of the stress urinary incontinence or a greater perceived quality of life related to incontinence.

Detailed description

The intervention group will perform the pelvic floor muscle trainning (PFMT) plus the use of vaginal spheres, while the control group will perform the PFMT treatment only, daily at home. The study will be conducted on women with stress urinary incontinence. The intervention will last four months and will consist of a monthly session with the physiotherapist, doing a total of 4 sessions and the final assessment.

Interventions

DEVICEIntervention group with Enna pelvic ball

The home guideline for placement of the vaginal spheres will be as described in next: st-2nd week 15 minutes, 1 time a day nd-4th week 30 minutes, 1 time a day 4th-8th week 1 hour, 1 time a day 8th-12th week 2 hours, 1 time a day 12th-16th week 3 hours, 1 time a day

OTHERControl group

According to the PERFECT score, a daily home guideline for the performance of PFMT will be requested three times a day, two types of exercises (endurance and strength), and eight repetitions of each.

Sponsors

RAPbarcelona
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women aged 18 or over * Suffer from stress urinary incontinence or mixed urinary incontinence. * Understand Spanish to be able to self-complete the questionnaires (validated in Spanish).

Exclusion criteria

* Not giving informed consent. * Women with faecal incontinence. * Women with grade III-IV prolapse. * Women with pathology that can affect the neuro-muscular response. * Women with incontinence that is not of functional origin. * Women who have perineal pain that makes it impossible to apply the spheres. * Women with an open vagina of more than 2.5 cm opening * Being pregnant. * Not being committed to complying with a minimum of 80% of the treatment. * Having previously started other pelvic physiotherapy treatments

Design outcomes

Primary

MeasureTime frameDescription
Severity of urinary incontinence using the ICIQ-SF questionnaire (International Consultation on Incontinence Questionnaire Short form) at Week 16.Time Frame: Baseline and Week 16The ICIQ-SF is a validated self-reported instrument assessing the urinary incontinence severity and It's quality of life. Possible scores range from 0 (no incontinence) to 21 (severe incontinence). Change=(Week 16 score - baseline score).

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026